We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,952

Life Sciences: Compliance and enforcement in the European Union
  • Hogan Lovells
  • European Union, Global
  • February 24 2017

A structured guide to compliance and dishonest practices in the European Union


Brexit - The Japanese perspective
  • Hogan Lovells
  • European Union, Japan, United Kingdom
  • March 22 2017

"There are numerous Japanese businesses operating in Europe, which have created 440,000 jobs. A considerable number of these firms are concentrated


DSM Watch: The new copyright directive - What will happen to the liability privilege of platforms?
  • Hogan Lovells
  • European Union
  • March 20 2017

Since the first proposals for amendments to the European Commission’s draft copyright directive were leaked earlier this month, we have seen quite


Clinical trials in the European Union
  • Hogan Lovells
  • European Union, Global
  • February 24 2017

A structured guide to clinical trials in the European Union


EU antitrust enforcement 2.0 - European Commission raises concerns about algorithms and encourages individual whistleblowers
  • Hogan Lovells
  • European Union, United Kingdom
  • March 17 2017

The European Competition Commissioner Margrethe Vestager has emphasised two important developments for EU antitrust enforcement, which have emerged


Germany suggests ramping up regulation of Digital Platforms by establishing a “Digital Agency” with a robust antitrust mandate
  • Hogan Lovells
  • European Union, Germany
  • March 23 2017

Will Germany establish a “Digital Agency” to monitor compliance with competition law rules in digital markets? Will a German “Digital Antitrust


New rules on payment terms
  • Hogan Lovells
  • European Union
  • May 2 2013

New rules which control the payment terms in most contracts involving European Union businesses are now in force. This note summarises the effect of


Brexit FAQ: Regulation of medical devices
  • Hogan Lovells
  • European Union, United Kingdom
  • March 13 2017

Life sciences companies with operations in the UK or Europe are wondering where to even start when it comes to Brexit-related legal issues. To give


Brexometer Survey - March 2017, Don’t step back, step forward: Global businesses looking ahead to Brexit
  • Hogan Lovells
  • European Union, United Kingdom
  • March 22 2017

The UK Government has set out a bold vision for a post-Brexit world: The UK as a global pivot; a strategic partnership with the EU; an enduring and


Brexit Ahead for TMT 8 months’ on
  • Hogan Lovells
  • European Union, United Kingdom
  • March 22 2017

Eight months ago, just before the Referendum, I anticipated the implications of a Leave vote for the sector. Today sees the publication of the first